Adjuvant Radiotherapy's Effect on One and Two Stages Prosthetic Breast Reconstruction and on Autologous Reconstruction

Sponsor
Humanitas Clinical and Research Center (Other)
Overall Status
Completed
CT.gov ID
NCT04783818
Collaborator
Marco Klinger (Other), Marta Scorsetti (Other), Davide Franceschini (Other), Emanuela Morenghi (Other)
3,200
1
7.7
418

Study Details

Study Description

Brief Summary

For patients with breast cancer subject to a mastectomy, preserving the morphology of the breast with immediate reconstruction is a crucial aspect to preserve the quality of life.

There are several types of breast reconstruction: prosthetic in one or two stages and autologous reconstruction.

Adjuvant radiotherapy has shown an improvement of the overall survival and of the local control for patients with positive lymph nodes.

Despite the undoubted cancer benefits, several studies have shown the negative impact of radiotherapy on breast reconstruction.

However, there are few studies with a significant number that evaluate the effect of radiotherapy on the three types of reconstruction.

In particular, given the extreme variability in clinical approaches, there is no certainty about the best reconstructive timing compared to radiotherapy, the iterations with dermic matrices as well as the usefulness of ancillary procedures such as autologous adipose grafting.

The aim of this study is to compare retrospectively these three types of reconstruction techniques to evaluate the effect of radiotherapy on different reconstructive modes.

Condition or Disease Intervention/Treatment Phase
  • Radiation: Adjuvant Radiotherapy

Study Design

Study Type:
Observational
Actual Enrollment :
3200 participants
Observational Model:
Case-Control
Time Perspective:
Retrospective
Official Title:
Multicenter Retrospective Evaluation Study of the Adjuvant Radiotherapy's Effect on One and Two Stages Prosthetic Breast Reconstruction and on Autologous Reconstruction
Actual Study Start Date :
Jun 6, 2020
Actual Primary Completion Date :
Nov 23, 2020
Actual Study Completion Date :
Jan 25, 2021

Arms and Interventions

Arm Intervention/Treatment
One Stage Reconstruction With Adjuvant Radiotherapy

Radiation: Adjuvant Radiotherapy
PMRT

Two Stage Reconstruction With Adjuvant Radiotherapy

Radiation: Adjuvant Radiotherapy
PMRT

Autologous Reconstruction With Adjuvant Radiotherapy

Radiation: Adjuvant Radiotherapy
PMRT

One Stage Reconstruction Without Adjuvant Radiotherapy

Two Stage Reconstruction Without Adjuvant Radiotherapy

Autologous Reconstruction Without Adjuvant Radiotherapy

Outcome Measures

Primary Outcome Measures

  1. Reconstruction failure [2 years]

    Complication rate (as hematoma, seroma, prosthetic exposure, skin and fat necrosis) that resulted in explant (prosthetic, expander or flap)

Secondary Outcome Measures

  1. Reconstruction Complications [2 years]

    Rate of capsular contracture and rate of need for reintervention

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 80 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patients subjected to mastectomy and immediate reconstruction directly with prostheses, in two times and by autologue flaps (TRAM, Latissimus Dorsi Flap, DIEP and any other method)
Exclusion Criteria:
  • Delayed prosthetic reconstruction

Contacts and Locations

Locations

Site City State Country Postal Code
1 Istituto Clinico Humanitas Rozzano Milan Italy 20089

Sponsors and Collaborators

  • Humanitas Clinical and Research Center
  • Marco Klinger
  • Marta Scorsetti
  • Davide Franceschini
  • Emanuela Morenghi

Investigators

  • Study Director: Marco Klinger, Humanitas Hospital, Italy
  • Study Chair: Davide Franceschini, Humanitas Hospital, Italy

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Andrea Lisa, Principal Investigator, Humanitas Clinical and Research Center
ClinicalTrials.gov Identifier:
NCT04783818
Other Study ID Numbers:
  • 49/20
First Posted:
Mar 5, 2021
Last Update Posted:
Mar 9, 2021
Last Verified:
Mar 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No

Study Results

No Results Posted as of Mar 9, 2021